These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3289523)

  • 21. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
    Roy-Byrne PP; Dager SR; Cowley DS; Vitaliano P; Dunner DL
    Am J Psychiatry; 1989 Jul; 146(7):860-5. PubMed ID: 2742010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
    Rickels K; Schweizer E; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R; Lamontagne Y
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diazepam in high doses is effective in schizophrenia.
    Nestoros JN; Suranyi-Cadotte BE; Spees RC; Schwartz G; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):513-6. PubMed ID: 6891818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients.
    Spina E; De Domenico P; Ruello C; Longobardo N; Gitto C; Ancione M; Di Rosa AE; Caputi AP
    Int Clin Psychopharmacol; 1994; 9(4):281-5. PubMed ID: 7868850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia.
    Convit A; Volavka J; Czobor P; de Asis J; Evangelista C
    Am J Psychiatry; 1994 Jan; 151(1):49-56. PubMed ID: 8267134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial.
    Bertolino A; Mastucci E; Porro V; Corfiati L; Palermo M; Ecari U; Ceccarelli G
    J Int Med Res; 1989; 17(5):455-60. PubMed ID: 2572494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placebo response in panic disorder.
    Coryell W; Noyes R
    Am J Psychiatry; 1988 Sep; 145(9):1138-40. PubMed ID: 3046384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment.
    Braun P; Greenberg D; Dasberg H; Lerer B
    J Clin Psychiatry; 1990 Jun; 51(6):236-8. PubMed ID: 2189869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
    Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
    Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
    Heresco-Levy U; Javitt DC; Ermilov M; Mordel C; Silipo G; Lichtenstein M
    Arch Gen Psychiatry; 1999 Jan; 56(1):29-36. PubMed ID: 9892253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
    Whiteford HA; Stedman TJ; Welham J; Csernansky JG; Pond SM
    J Clin Psychopharmacol; 1992 Oct; 12(5):337-40. PubMed ID: 1362205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC; Burrows GD; DuPont RL; Lesser IM; Noyes R; Pecknold JC; Rifkin A; Swinson RP
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS; Last B; Getson A; Reines SA
    Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.